WA
TEVA icon

WealthTrust-Arizona’s Teva Pharmaceuticals TEVA Stock Holding History

WealthTrust-Arizona’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-75
Closed -$4K – 611
2015
Q3 		$4K Sell
75
-1,319
-95% -$85.5K ﹤0.01% 501
2015
Q2 		$82K Hold
1,394
– – 0.05% 106
2015
Q1 		$87K Sell
1,394
-247
-15% -$14.4K 0.05% 103
2014
Q4 		$94K Buy
1,641
+1,591
+3,182% +$88.6K 0.08% 103
2014
Q3 		$3K Sell
50
-10
-17% -$530 ﹤0.01% 538
2014
Q2 		$3K Buy
60
+44
+275% +$2.25K ﹤0.01% 531
2014
Q1 		$1K Hold
16
– – ﹤0.01% 656
2013
Q4 		$1K Hold
16
– – ﹤0.01% 625
2013
Q3 		$1K Hold
16
– – ﹤0.01% 623
2013
Q2 		$1K Buy
+16
New +$623 ﹤0.01% 605

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WealthTrust-Arizona's TEVA Position: Q4 2015 in Review

WealthTrust-Arizona sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 75 shares — an estimated $4K sold.

WealthTrust-Arizona first reported a position in TEVA in Q2 2013 and held it in 10 quarters. The position peaked at $94K in Q4 2014. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • WealthTrust-Arizona reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • WealthTrust-Arizona sold 75 Teva Pharmaceuticals shares in Q4 2015, an estimated $4K.
  • WealthTrust-Arizona first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • WealthTrust-Arizona's Teva Pharmaceuticals position peaked at $94K in Q4 2014.
  • 876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on WealthTrust-Arizona's 13F filing for Q4 2015, filed 26 Jan 2016.